(Q34731031)

4 August 2017

title

Long-Term Outcome of an HIV-Treatment Programme in Rural Africa: Viral Suppression despite Early Mortality (English)

1 reference

4 August 2017

Roos E Barth

1

1 reference

4 August 2017

Hugo A Tempelman

series ordinal

2

1 reference

4 August 2017

Robert Moraba

series ordinal

3

1 reference

4 August 2017

Andy I M Hoepelman

series ordinal

4

1 reference

4 August 2017

publication date

21 November 2010

1 reference

AIDS Research and Treatment

4 August 2017

published in

1 reference

4 August 2017

volume

2011

1 reference

4 August 2017

page(s)

434375

1 reference

Creative Commons Attribution 3.0 Unported

4 August 2017

copyright license

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065919

Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065919

Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065919

Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065919

Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065919

Antiretroviral therapy and early mortality in South Africa

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065919

Increased mortality of male adults with AIDS related to poor compliance to antiretroviral therapy in Malawi

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065919

Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065919

Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065919

Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065919

Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065919

Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa

7 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F434375

Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F434375

Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F434375

Low Levels of Antiretroviral‐Resistant HIV Infection in a Routine Clinic in Cameroon that Uses the World Health Organization (WHO) Public Health Approach to Monitor Antiretroviral Treatment and Adequacy with the WHO Recommendation for Second‐Line

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F434375

Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065919

Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065919

Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21490778

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settings

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21490778

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1155/2011/434375

1 reference

4 August 2017

1 reference

4 August 2017

1 reference